Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
Symbol
INDV on Nasdaq
Shares outstanding
125,610,040
Price per share
$32.97
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
112,919,452
Total reported value
$4,049,277,997
% of total 13F portfolios
0.01%
Share change
-4,624,355
Value change
-$22,998,820
Number of holders
241
Price from insider filings
$32.97
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% +107% $638,884,065 +$335,082,637 17,806,183 +110% BlackRock, Inc. 31 Dec 2025
Oaktree Capital Holdings, LLC 5.7% -19% $232,808,746 -$53,592,755 7,108,664 -19% Oaktree Capital Holdings, LLC 24 Dec 2025
FULLER & THALER ASSET MANAGEMENT, INC. 5.1% $216,632,146 6,371,534 Fuller & Thaler Asset Management, Inc. 31 Dec 2025
Madison Avenue Partners, LP 5% -17% $213,537,068 -$39,360,134 6,280,502 -16% Madison Avenue International LP 31 Dec 2025
Two Seas Capital LP 5% -12% $203,438,218 -$27,837,500 6,211,854 -12% Two Seas Capital LP 23 Dec 2025
MORGAN STANLEY 3.7% $53,976,433 4,665,206 Morgan Stanley 31 Mar 2025
Flynn James E 3.7% -60% $111,255,547 -$143,518,681 4,614,498 -56% Deerfield Mgmt, L.P. 10 Nov 2025
GOLDMAN SACHS GROUP INC 2.9% -46% $122,142,647 -$99,940,892 3,592,431 -45% THE GOLDMAN SACHS GROUP, INC. 31 Dec 2025
MILLENNIUM MANAGEMENT LLC 2% $80,609,868 2,461,370 Millennium Management LLC 15 Dec 2025

As of 31 Dec 2025, 241 institutional investors reported holding 112,919,452 shares of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV). This represents 90% of the company’s total 125,610,040 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) together control 72% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 18,230,539 +109% 0.01% $654,111,738
OAKTREE CAPITAL MANAGEMENT LP 5.7% 7,108,644 0% 4.1% $255,058,964
FULLER & THALER ASSET MANAGEMENT, INC. 5.1% 6,371,534 +101% 0.77% $228,610,629
VANGUARD GROUP INC 4.4% 5,473,891 +58% 0% $196,403,209
Two Seas Capital LP 4.1% 5,109,198 -51% 11% $183,318,024
STATE STREET CORP 3.7% 4,659,281 +66% 0.01% $167,175,002
MORGAN STANLEY 3.5% 4,377,774 -22% 0.01% $157,074,532
DEERFIELD MANAGEMENT COMPANY, L.P. 2.7% 3,393,063 -51% 1.6% $121,743,100
GOLDMAN SACHS GROUP INC 2.5% 3,177,867 -52% 0.02% $114,021,868
ACADIAN ASSET MANAGEMENT LLC 2.5% 3,085,113 +7% 0.18% $109,505,000
CITADEL ADVISORS LLC 2.4% 3,061,902 +17% 0.07% $109,861,044
GEODE CAPITAL MANAGEMENT, LLC 2.3% 2,837,824 -0.65% 0.01% $101,840,214
Divisadero Street Capital Management, LP 2.2% 2,784,786 -17% 5.7% $99,918,122
MANGROVE PARTNERS IM, LLC 2.2% 2,746,009 +0.13% 8% $98,526,803
Newtyn Management, LLC 2% 2,534,538 -40% 9.6% $90,939,223
MILLENNIUM MANAGEMENT LLC 1.9% 2,337,685 +1.2% 0.06% $83,876,138
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 1.8% 2,304,545 0.14% $82,687,075
BARCLAYS PLC 1.5% 1,878,157 -12% 0.03% $67,388,274
Point72 Asset Management, L.P. 1.5% 1,821,872 -36% 0.1% $65,368,767
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.4% 1,705,900 0.04% $61,207,692
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.99% 1,243,593 +8.3% 0.01% $44,620,117
GOLDENTREE ASSET MANAGEMENT LP 0.99% 1,241,482 -30% 2.4% $44,460,908
SOROS FUND MANAGEMENT LLC 0.92% 1,154,452 -15% 0.56% $41,421,738
DIMENSIONAL FUND ADVISORS LP 0.89% 1,118,169 +86% 0.01% $40,118,826
GENDELL JEFFREY L 0.87% 1,096,343 +4.8% 0.69% $39,336,787

Institutional Holders of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 112,919,452 $4,049,277,997 -$22,998,820 $35.88 241
2025 Q3 110,811,392 $2,670,071,230 +$380,369,121 $24.11 196
2025 Q2 106,959,206 $1,577,697,144 +$260,685,760 $14.74 119
2025 Q1 91,341,313 $865,955,709 +$119,981,356 $9.53 115
2024 Q4 77,790,536 $974,764,447 +$68,457,241 $12.43 112
2024 Q3 71,540,427 $699,253,141 +$54,237,351 $9.75 100
2024 Q2 64,306,768 $1,024,584,616 -$11,033,099 $16.12 95
2024 Q1 63,276,125 $1,352,112,050 +$24,497,831 $21.42 86
2023 Q4 63,746,436 $970,147,653 -$75,831,576 $15.27 69
2023 Q3 67,913,856 $1,531,662,383 +$134,844,672 $21.99 72
2023 Q2 61,447,059 $1,522,893,399 +$1,522,893,346 $23.80 56